Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb:66:90-100.
doi: 10.1016/j.addr.2013.09.007. Epub 2013 Sep 22.

Molecular imaging for cancer diagnosis and surgery

Affiliations
Review

Molecular imaging for cancer diagnosis and surgery

Timon Hussain et al. Adv Drug Deliv Rev. 2014 Feb.

Abstract

Novel molecular imaging techniques have the potential to significantly enhance the diagnostic and therapeutic approaches for cancer treatment. For solid tumors in particular, novel molecular enhancers for imaging modalities such as US, CT, MRI and PET may facilitate earlier and more accurate diagnosis and staging which are prerequisites for successful surgical therapy. Enzymatically activatable "smart" molecular MRI probes seem particularly promising because of their potential to image tumors before and after surgical removal without re-administration of the probe to evaluate completeness of surgical resection. Furthermore, the use of "smart" MR probes as part of screening programs may enable detection of small tumors throughout the body in at-risk patient populations. Dual labeling of molecular MR probes with fluorescent dyes can add real time intraoperative guidance facilitating complete tumor resection and preservation of important structures. A truly theranostic approach with the further addition of therapeutic agents to the molecular probe for adjuvant therapy is conceivable for the future.

Keywords: Cancer diagnosis; Fluorescence guided surgery; Molecular imaging.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Preoperative MRI image of a mouse injected with gadolinium and Cy5 dual-labeled ACPPD showing contrast uptake in tumor (A, black arrow pointing to the tumor). Repeat MRI (B) following tumor removal surgery showed a small area of tissue with increased gadolinium uptake (C inset, white arrowhead). Histological analysis confirmed the presence of cancer cells (C). Scale bar 100 μm. (Adapted and reprinted from reference .)
Figure 2
Figure 2. Fluorescent labeling facilitates intraoperative tumor identification
In a parotid gland cancer model of a mouse, no tumor is immediately apparent in the white light image (A, the yellow outline indicates the extent of the tumor, white arrows point to branches of the facial nerve). Under fluorescence guidance with a fluorescently labeled ACPP, the tumor and its extent are easily identifiable (B: fluorescent image, C: color overlay).
Figure 3
Figure 3. Enhanced nerve visualization
The identification of the branches of a right facial nerve of a mouse is enhanced by fluorescent molecular probe labeling (B) compared to the white light image (A). Large superficial branches (white arrows) can be easily identified even under white light alone, visualization of smaller branches is clearly improved by fluorescence imaging.

References

    1. American College of Surgeons National Cancer Database Public Reports [accessed 05.02.2013];2013 http://www.cromwell.facs.org/BMarks/BMPub/Ver10/bm_reports.cfm.
    1. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition) Chest. 2007;132:234S–242S. - PubMed
    1. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346:92–98. - PubMed
    1. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008;452:580–589. - PMC - PubMed
    1. Kircher MF, Willmann JK. Molecular body imaging: MR imaging, CT, and US. part I. principles. Radiology. 2012;263:633–643. - PMC - PubMed

Publication types